Livongo Health (NASDAQ:LVGO) Shares Down 5.1%

Shares of Livongo Health (NASDAQ:LVGO) were down 5.1% during trading on Thursday . The stock traded as low as $24.87 and last traded at $25.36, approximately 519,000 shares traded hands during trading. A decline of 54% from the average daily volume of 1,116,516 shares. The stock had previously closed at $26.71.

Several equities analysts have commented on LVGO shares. Needham & Company LLC started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set a “buy” rating and a $42.00 price objective for the company. Svb Leerink started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set an “outperform” rating and a $50.00 price objective for the company. Morgan Stanley upgraded shares of Livongo Health from an “equal weight” rating to an “overweight” rating and set a $42.00 price objective for the company in a research report on Wednesday, August 28th. KeyCorp started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set an “overweight” rating and a $46.00 price objective for the company. Finally, Leerink Swann started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set an “outperform” rating and a $50.00 price objective for the company. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $44.30.

The company has a fifty day moving average price of $20.51.

Livongo Health (NASDAQ:LVGO) last released its earnings results on Wednesday, November 6th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.28) by $0.23. The firm had revenue of $46.70 million during the quarter, compared to the consensus estimate of $42.77 million. Livongo Health’s revenue was up 148.7% compared to the same quarter last year. During the same quarter last year, the business posted ($0.55) EPS. As a group, equities research analysts anticipate that Livongo Health will post -1.38 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers bought a new stake in shares of Livongo Health in the 3rd quarter worth about $238,000. Dean Capital Investments Management LLC bought a new stake in shares of Livongo Health in the 3rd quarter worth about $275,000. Pembroke Management LTD bought a new stake in shares of Livongo Health in the 3rd quarter worth about $1,128,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Livongo Health in the 3rd quarter worth about $1,292,000. Finally, Emerald Advisers LLC bought a new stake in shares of Livongo Health in the 3rd quarter worth about $1,342,000. Hedge funds and other institutional investors own 0.28% of the company’s stock.

About Livongo Health (NASDAQ:LVGO)

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Further Reading: Do investors pay a separate front-end load every time they buy additional shares?

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.